4D Molecular Therapeutics, Inc. (FDMT) Presents at Jefferies Global Healthcare Conference 2026 Transcript
4D Molecular Therapeutics, Inc. presented at the Jefferies Global Healthcare Conference 2026. The company focuses on gene therapies, particularly for conditions like wet AMD. Key executives, including CEO David Kirn, participated in the event to discuss their innovative approaches and programs.
- ▪4D Molecular Therapeutics, Inc. is working on gene therapies aimed at treating various conditions.
- ▪The company highlighted its lead program focused on wet age-related macular degeneration (AMD).
- ▪David Kirn, the CEO, introduced the company during the presentation at the conference.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4912510-4d-molecular-therapeutics-inc-fdmt-presents-at-jefferies-global-healthcare-conference-2026"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
